New Tacrine Dimers Alleviate the Intracellular Amyloid-β-induced Cognitive Disturbance and Oxidative Stress in Mice

This study aimed to investigate <italic>in vivo</italic> and <italic>ex-vivo</italic> the effects of tacrine dimers (TD1, TD2, TD3 and TD4) in mice with Alzheimer's disease (AD) induced by amyloid peptide (A<italic>β</italic>42) and, respectively, evaluated in behavioral tests of cognition, oxidative stress and neuroinflammation. All dimers reduced the cognitive deficit caused by A<italic>β</italic>42, oxidative stress and neuroinflammation, especially the compound TD4. By ADMET analysis (SwissADME and pkCSM 2.10 platforms), TD4 exhibited favorable pharmacokinetic properties with the control drug. The results suggest a therapeutic potential for AD for these compounds, given their distinct cognitive and neuroprotective effects in AD models induced by A<italic>β</italic>42.

Authors

Institutions

Publication Details

Journal
Anais da Academia Brasileira de Ciências
Published
2025-01-01
DOI
https://doi.org/10.1590/0001-3765202520241163
Primary Topic
Cholinesterase and Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Tacrine Dimers Alleviate the Intracellular Amyloid-β-induced Cognitive Disturbance and Oxidative Stress in Mice

Sumbal Saba, Yuri de Freitas Rego, Luísa Mota da Silva, Jamal Rafique et al.
Anais da Academia Brasileira de Ciências
Cholinesterase and Neurodegenerative Diseases
article

New Tacrine Dimers Alleviate the Intracellular Amyloid-β-induced Cognitive Disturbance and Oxidative Stress in Mice

Sumbal Saba, Yuri de Freitas Rego, Luísa Mota da Silva, Jamal Rafique, Márcia María de Souza, Clara Herrera‐Arozamena, Thiago Henrique Doring, Marı́a Isabel Rodrı́guez-Franco, Aldo Sena de Oliveira, Ângelo de Fátima, Ana Elisa Gonçalves, Maria Lı́gia Rodrigues Macedo, LUCAS AUGUSTO ARAUJO, OTTO SPIGARIOL
article en

Abstract

This study aimed to investigate <italic>in vivo</italic> and <italic>ex-vivo</italic> the effects of tacrine dimers (TD1, TD2, TD3 and TD4) in mice with Alzheimer's disease (AD) induced by amyloid peptide (A<italic>β</italic>42) and, respectively, evaluated in behavioral tests of cognition, oxidative stress and neuroinflammation. All dimers reduced the cognitive deficit caused by A<italic>β</italic>42, oxidative stress and neuroinflammation, especially the compound TD4. By ADMET analysis (SwissADME and pkCSM 2.10 platforms), TD4 exhibited favorable pharmacokinetic properties with the control drug. The results suggest a therapeutic potential for AD for these compounds, given their distinct cognitive and neuroprotective effects in AD models induced by A<italic>β</italic>42.

Anais da Academia Brasileira de CiênciasVol. 97(suppl 2)
Universidade Federal de Minas Gerais (BR), Universidade Federal de Mato Grosso do Sul (BR), Universidade Federal de Santa Catarina (BR), Instituto de Química Médica (ES), Universidade do Vale do Itajaí (BR), Universidade Federal de Goiás (BR)
Ministerio de Ciencia, Innovación y Universidades, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Fundação de Amparo à Pesquisa do Estado de Goiás, Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
Good health and well-being
Openalex Percentile: Top 79%
Cholinesterase and Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.